Wang Zhiwei, Ahmad Aamir, Li Yiwei, Kong Dejuan, Azmi Asfar S, Banerjee Sanjeev, Sarkar Fazlul H
Department of Pathology, Karmanos Cancer Institute, Wayne State University, School of Medicine, Detroit, MI 48201, USA.
Biochim Biophys Acta. 2010 Aug;1806(1):122-30. doi: 10.1016/j.bbcan.2010.04.003. Epub 2010 Apr 28.
Platelet-derived growth factor-D (PDGF-D) can regulate many cellular processes, including cell proliferation, apoptosis, transformation, migration, invasion, angiogenesis and metastasis. Therefore PDGF-D signaling has been considered to be important in human malignancies, and thus PDGF-D signaling may represent a novel therapeutic target, and as such suggests that the development of agents that will target PDGF-D signaling is likely to have a significant therapeutic impact on human cancers. This mini-review describes the mechanisms of signal transduction associated with PDGF-D signaling to support the role of PDGF-D in the carcinogenesis. Moreover, we summarize data on several PDGF-D inhibitors especially naturally occurring "chemopreventive agent" such an indole compound, which we believe could serve as a novel agent for the prevention of tumor progression and/or treatment of human malignancies by targeted inactivation of PDGF-D signaling.
血小板衍生生长因子-D(PDGF-D)可调节许多细胞过程,包括细胞增殖、凋亡、转化、迁移、侵袭、血管生成和转移。因此,PDGF-D信号传导被认为在人类恶性肿瘤中很重要,因此PDGF-D信号传导可能代表一个新的治疗靶点,这表明开发靶向PDGF-D信号传导的药物可能对人类癌症产生重大治疗影响。本综述描述了与PDGF-D信号传导相关的信号转导机制,以支持PDGF-D在致癌过程中的作用。此外,我们总结了几种PDGF-D抑制剂的数据,特别是天然存在的“化学预防剂”,如吲哚化合物,我们认为它可以通过靶向失活PDGF-D信号传导,作为预防肿瘤进展和/或治疗人类恶性肿瘤的新型药物。